We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Raman Microscopy Technique Achieves High-Resolution Images of Biological Samples

By LabMedica International staff writers
Posted on 31 Dec 2024

Understanding the behavior of the molecules and cells that make up our bodies is essential for advancing medical science. More...

This has driven ongoing efforts to obtain clear images of biological processes beyond what the human eye can observe. Raman microscopy is an effective imaging technique for biological samples, as it can provide chemical insights into specific molecules, such as proteins, involved in bodily functions. However, the Raman light emitted by biological samples is weak, often leading to the signal being drowned out by background noise, which results in low-quality images. Researchers have employed cryogenic freezing in a new study to enhance the resolution of Raman microscopy images of biological samples.

The study published in Science Advances by researchers at Osaka University (Osaka, Japan) presents a method for achieving high-resolution Raman microscopy images. The team developed a microscope capable of maintaining the temperature of samples that had been frozen before imaging. This technique allowed the researchers to produce images that are up to eight times brighter than those previously obtained with Raman microscopy. Importantly, this method does not require staining or chemicals to fix the cells, enabling a more authentic view of cellular processes and behavior.

Furthermore, the researchers confirmed that the freezing process preserved the physicochemical states of various proteins, providing a key advantage over traditional chemical fixation methods. The new cryofixing technique can be integrated with other microscopy approaches, allowing for more detailed analysis of biological samples. It holds significant potential for a broad range of applications in the biological sciences, including medicine and pharmaceuticals.

"One of the main reasons for blurry images is the motion of the things you’re trying to look at," said Kenta Mizushima, lead author of the study. "By imaging frozen samples that were unable to move, we could use longer exposure times without damaging the samples. This led to high signals compared with the background, high resolution, and larger fields of view."


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Portable POCT Blood Gas Analyzer
BD100
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Blood Protein Analysis Reveals Menopause-Associated Signals of Brain Aging

Menopause affects women across midlife and is often accompanied by endocrine changes, hot flashes, brain fog and sleep disturbances. Women spend roughly one third of their lives after the menopause transition,... Read more

Molecular Diagnostics

view channel
Image: These images show breast tumors in a new preclinical model developed by Garvan researchers. The cells carry a fluorescent sensor that lights up blue/green when CDK1—the protein \'engine\' cells need to divide—is switched on. Using it, the team watched CDK1 activity rise as tumors became invasive and stay high in tumors that kept growing despite treatment. (Image Credit: Dr. Max Nobis / Garvan Institute)

Study Finds Potential Marker of Targeted Drug Resistance in Breast Cancer

Estrogen receptor-positive breast cancer is the most common breast cancer subtype and is driven by estrogen. Many patients are treated with CDK4/6 inhibitors alongside hormone therapy, but these drugs... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image: Four-quadrant streaking of fecal samples on chromogenic UTI agar shows various patterns of relative bacterial species abundance. The assorted shapes of the pinkish colonies indicate different E. coli strains. (Photo courtesy of Sokurenko Lab)

Stool Testing Predicts UTI Risk and Guides Antibiotic Selection

Urinary tract infections (UTIs) are a common reason for antibiotic prescribing in general medical practice and can be painful in postmenopausal women, sometimes progressing to kidney infection or life-threatening... Read more

Industry

view channel
Image: The ExaccType ESR1 dPCR Kit uses digital PCR technology to detect key ESR1 mutations associated with acquired resistance to endocrine therapy. (Photo courtesy of  BIOTYPE)

Collaboration Expands Access to Tests for Cancer Treatment Resistance and Toxicity Risk

Precision medicine in oncology relies on molecular testing to identify biomarkers that can help guide treatment decisions. In hormone receptor-positive, HER2-negative metastatic breast cancer, ESR1 mutations... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.